Compare NERV & LARK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NERV | LARK |
|---|---|---|
| Founded | 2007 | 1885 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 210.1M | 185.5M |
| IPO Year | 2014 | 2001 |
| Metric | NERV | LARK |
|---|---|---|
| Price | $4.11 | $30.37 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $10.50 | N/A |
| AVG Volume (30 Days) | ★ 358.2K | 13.7K |
| Earning Date | 05-01-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 3.07% |
| EPS Growth | N/A | ★ 35.84 |
| EPS | N/A | ★ 0.83 |
| Revenue | ★ $41,175,600.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $37.23 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.76 | $23.57 |
| 52 Week High | $12.46 | $32.39 |
| Indicator | NERV | LARK |
|---|---|---|
| Relative Strength Index (RSI) | 40.62 | 60.04 |
| Support Level | $3.80 | $25.29 |
| Resistance Level | $4.59 | $32.39 |
| Average True Range (ATR) | 0.38 | 0.53 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 18.81 | 79.81 |
Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.
Landmark Bancorp Inc is the bank holding company for Landmark National Bank, which is dedicated to providing quality financial and banking services. The Bank has continued to focus on increasing its originations of commercial, commercial real estate (CRE), and agricultural loans, which management believes will be more profitable and provide more growth for the Bank than traditional one-to-four-family residential real estate lending. In addition, it also invests in certain investment and mortgage-related securities using deposits and other borrowings as funding sources. Its primary deposit gathering and lending markets are geographically diversified with locations in central, eastern, southeast, and Southwest Kansas.